Diagnostic Delay, Comorbid Hidradenitis Suppurativa and the Prognostic Value of Bacterial Culture in Folliculitis Decalvans: A Cohort Study

Adalimumab improved folliculitis decalvans in most patients.

Tofacitinib may effectively treat folliculitis decalvans.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Accurate diagnosis and tailored treatment are crucial for managing complex hair loss conditions.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Folliculitis decalvans and tufted folliculitis are related, and a new treatment with rifampicin and clindamycin is effective.